Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants

Overview of attention for article published in JAMA: Journal of the American Medical Association, December 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 3 news outlets
blogs: 5 blogs
twitter: 52 X users
facebook: 1 Facebook page

video: 1 YouTube creator
guideline: 1 clinical guideline source
bluesky: 18 Bluesky users
podcasts: 3 podcasts

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 20 Bluesky posts from 18 Bluesky users, with an upper bound of 64,368 followers.

Early intratracheal budesonide showed minimal impact on survival free of bronchopulmonary dysplasia in extremely preterm infants. by Manley BJ, Kamlin COF (...) McKinlay CJD et 27 al. in JAMA #MedSky 📖 read the article:

RP @healthcare-global.bsky.social: jamanetwork.com/journals/jam...

RP @jama.com: In extremely preterm infants receiving surfactant, early intratracheal budesonide may have little to no effect on survival free of bronchopulmonary dysplasia. ja.ma/49DOGCa

jamanetwork.com/journals/jam...

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 16 additional Bluesky posts.